Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population
Abdouh, Ismail; Porter, Stephen; Fedele, Stefano; Elgendy, Nadia; Aboalshamat, Khalid; Babkair, Hamzah Ali; Ní Riordain, Richeal
Date:
2021-03-24
Copyright:
© 2021, John Wiley & Sons, Inc. This is the peer reviewed version of the following article: Abdouh, I., Porter, S., Fedele, S., Elledge, N., Aboalshamat, K., Babkair, H. A. and Ní Riordain, R. (2021) 'Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population', Journal of Oral Pathology & Medicine, 50 (8), pp. 812-819. doi: 10.1111/jop.13177, which has been published in final form at https://doi.org/10.1111/jop.13177. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
Citation:
Abdouh, I., Porter, S., Fedele, S., Elledge, N., Aboalshamat, K., Babkair, H. A. and Ní Riordain, R. (2021) 'Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population', Journal of Oral Pathology & Medicine, 50 (8), pp. 812-819. doi: 10.1111/jop.13177
Abstract:
Background: The objective of the present study was to identify the impact of systemic sclerosis (SSc) upon oral health-related quality of life (OHRQoL) of affected individuals resident in the UK.
Methods: A total of 100 patients and their partners or carers were invited to complete questionnaires regarding the impact of SSc on quality of life and psychological well-being using valid and reliable patient-reported outcome measures (OHIP-14, MHISS, OIDP, MDAS and HADS). A total of 50 patients with SSc and 18 partners or carers who acted as controls returned the completed questionnaires. Statistical analyses were performed for comparisons of different variables.
Results: All the mean scores of OHIP-14 (SSc [16.5 ± 12.4] Vs controls [6.06 ± 7.6, p = 0.001]) and MHISS components were significantly higher in patients than those of control group (SSc [21.26 ± 12] Vs controls [4.8 ± 7.3, p < 0.0001]). Majority of OIDP mean scores were significantly worse in patients compared with controls [SSc (10 ± 8.7) Vs controls (1.72 ± 3.4, p < 0.0001)]. The mean of total MDAS [SSc (11.7 ± 5.3) Vs controls (9.5 ± 4.4)] and HADS scores were higher in patients compared to controls (SSc depression [4.8 ± 3.3] and anxiety [6 ± 4.6] Vs controls [3.7 ± 3.1] [4.7 ± 3.9]).
Conclusions: Although the present study is limited by the low response rate and its cross-sectional design, present results highlighted that systemic sclerosis has a negative impact on OHRQoL of the affected individuals; hence, the evaluation of associated psychological impact including anxiety and depression symptoms is needed to better understand, monitor and evaluate the disease comorbidity in patients with SSc.
Show full item record
